Position in TRVI
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$536,850
-$1,090,750 QoQ
Shares Held
45,000
-65.4% QoQ
Ownership
0.032%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2025
5 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in TRVI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026BIT Capital GmbH holds $12,387,499 across 14 Biotechnology names. TRVI ranks #7 (4.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DFTX |
Definium Therapeutics, Inc.
|
277,511 | $5,244,957 | |
| 2 | NKTR |
Nektar Therapeutics
|
21,100 | $1,518,145 | |
| 3 | DNTH |
Dianthus Therapeutics, Inc. /DE/
|
12,000 | $1,007,040 | |
| 4 | BNTX |
BioNTech SE
|
9,147 | $812,985 | |
| 5 | ATAI |
AtaiBeckley Inc.
|
182,576 | $646,319 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
5,700 | $554,325 | |
| 7 | TRVI |
Trevi Therapeutics, Inc.
This page
|
45,000 | $536,850 | |
| 8 | ELDN |
Eledon Pharmaceuticals, Inc.
|
134,000 | $412,720 |
All Filings in TRVI
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $536,850 | 45,000 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $1,627,600 | 130,000 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $61,661 | 6,739 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $27,929 | 5,106 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $264,098 | 41,987 | Shares | Sole | 2025-05-09 | |
| No filing history on record for this holder in this stock. | ||||||